Form 4: Twist Bioscience CAO Sells Shares for Tax Obligations
Insider Transaction Report
Twist Bioscience's Chief Accounting Officer, Robert F. Werner, sold 160 shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Robert F. Werner, Chief Accounting Officer of Twist Bioscience Corp (TWST), reported a sale of common stock.
- The transaction involved the disposition of 160 shares of common stock on November 3, 2025.
- The shares were sold at a price of $32.0794 per share.
- The sale was mandated to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs).
- This was a 'sell to cover' transaction under the Issuer's equity incentive plans and does not represent a discretionary trade by Mr. Werner.
- Following the reported transaction, Mr. Werner beneficially owns 50,870 shares of common stock.
- The transaction was made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Sentiment
Score: 5
Explanation: The transaction is a mandatory 'sell to cover' for tax withholding obligations related to RSU vesting, not a discretionary sale. As such, it carries a neutral sentiment and does not indicate management's view on the company's prospects.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This is a routine insider transaction for tax purposes, common across all industries for executives receiving equity compensation. It does not reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not signal a change in insider sentiment or company fundamentals.
Key Dates
| Date | Description |
|---|---|
| 11/03/2025 | Date of earliest transaction (sale of 160 shares of common stock) |
| 11/05/2025 | Date the Form 4 was signed by Attorney-in-Fact for Robert F. Werner |
Keywords
Twist Bioscience, TWST, Insider Trading, Form 4, Stock Sale, Restricted Stock Units, Tax Withholding, Sell to Cover, Corporate Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.